Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-20 Purchase | 2021-12-21 9:41 pm | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 12,000 | $8.5663 | $102,796 | 23,295 (Direct) | View |
| 2020-11-03 Purchase | 2020-11-04 4:05 pm | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 250,000 | $24 | $6,000,000 | 289,695 (Indirect) | View |
| 2020-11-03 Purchase | 2020-11-03 9:36 pm | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 250,000 | $24 | $6,000,000 | 5,615,659 (Indirect) | View |
| 2020-11-03 Purchase | 2020-11-03 8:09 pm | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 41,666 | $24 | $999,984 | 820,019 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne CAO | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre CEO Chairman | 378,033 | $0 | 378,033 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 181,000 | $0 | 181,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:36 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:36 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:35 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:34 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:30 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 6:27 pm | N/A 2031-05-17 | Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director | 56,670 | $0 | 56,670 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:56 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre CEO Chairman | 640,000 | $0 | 640,000 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:55 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 160,050 | $0 | 160,050 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:52 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 148,850 | $0 | 148,850 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:51 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 117,300 | $0 | 117,300 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:51 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 145,500 | $0 | 145,500 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:50 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks | 71,750 | $0 | 71,750 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-05 4:01 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner | 12,822,710 | $0 | 6,411,355 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-04 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 3,388,838 | $0 | 289,695 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 9:36 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 10,731,318 | $0 | 5,615,659 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 22,590 | $0 | 11,295 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 1,519,212 | $0 | 820,019 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 266,008 | $0 | 633,004 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre CEO Chairman | 750,000 | $0 | 5,925,000 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner | 353,724 | $0 | 1,176,862 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:04 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 82,508 | $0 | 82,508 (Indirect) | View |
| 2020-10-29 Option Award | 2020-10-30 5:49 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:47 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:43 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:41 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:40 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:39 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Cheng Isaac Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:18 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Ownership | 2020-10-29 8:50 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 0 | $0 | 472,508 (Indirect) | View |
| 2020-10-29 Ownership | 2020-10-29 8:50 pm | N/A 2029-12-12 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks | 0 | $0 | 359,732 (Direct) | View |
| 2020-10-29 Ownership | 2020-10-29 8:50 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 0 | $0 | 175,000 (Direct) | View |